Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Dermatolog Treat ; 34(1): 2127308, 2023 Dec.
Article in English | MEDLINE | ID: mdl-36200741

ABSTRACT

Hyperhidrosis can significantly curtail patient quality of life, from debilitating physical symptoms to social stigmatization and reduced life opportunities. Current treatments often prove unsatisfactory, especially in sufferers of generalized hyperhidrosis. In this open trial, we present the case of a refractory generalized hyperhidrosis treated with cannabinoids. We found a remarkable reduction in the volume of sweat and an improvement to the patient's quality of life using this novel low-cost and low-impact approach.


Subject(s)
Cannabinoids , Hyperhidrosis , Humans , Cannabinoids/therapeutic use , Quality of Life , Hyperhidrosis/diagnosis , Sweating
2.
Eur J Dermatol ; 31(3): 392-395, 2021 Jun 01.
Article in English | MEDLINE | ID: mdl-34309523

ABSTRACT

BACKGROUND: Hand hygiene measures in the general population and in health care workers have increased considerably since the outbreak of the COVID-19 pandemic. OBJECTIVES: To investigate the prevalence and symptoms of hand eczema, as well as hygiene measures and concepts of care, in German health care workers. MATERIALS & METHODS: This was an observational questionnaire study to investigate hygiene and skin care habits, as well as the prevalence and symptoms of hand eczema in 66 nurses and doctors of our dermatology department before and during the SARS-CoV-2 pandemic. RESULTS: Hand washing and hand disinfection procedures increased significantly during the COVID-19 pandemic. Self-diagnosed hand eczema was reported by 33% of the participants, with a median duration of 14 days. The majority of staff currently affected by hand eczema were free of eczema a month previously (82%) and would treat their skin condition with emollients (77%). Erythema, scaling, burning and fissures were reported by 66.1% of the participants and were classified as predominant signs of toxic-irritant hand dermatitis rather than contact allergy. CONCLUSION: Overall, the SARS-CoV-2 pandemic has led to a significant increase in the incidence of signs of irritant hand eczema despite intensified emollient use as a preventive measure. Awareness of the prevalence of hand eczema in health care workers in Germany during the COVID-19 pandemic should be raised, and preventive measures should be intensified.


Subject(s)
COVID-19/prevention & control , Dermatitis, Irritant/epidemiology , Dermatitis, Occupational/epidemiology , Hand Dermatoses/epidemiology , Hand Disinfection , Medical Staff, Hospital , Nursing Staff, Hospital , Germany/epidemiology , Humans , Pandemics , Prevalence , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL
...